Due to robust multiplexing, LSSL technology potentially delivers more data in less time than other bioassay products, ELISA and PCR based assays and Microarray. The technology offers several other distinct advantages over traditional methods:

Speed/High Throughput — because each set of colored NanoBindi serves as an individual test; a large number of different bioassays can be performed and analyzed simultaneously 

Versatility — A single LSSL technology-based system can perform bioassays in several different formats, including nucleic acids and antigen-antibody binding, along with enzyme, receptor-ligand and other protein or small molecule interactions 

Flexibility — The technology can be customized for the user’s specific needs or updated periodically by attaching a specific probe to a uniquely colored NanoBindi

Accuracy — The technology generates real-time analysis and accurate quantification of the biological interactions

Reproducibility — High-volume production of NanoBindi within a single lot allows assay standardization that solid-phased flat arrays cannot provide

Multi-parameter Testing – ability to covalently bind number of different affinity molecules to NanoBindi with specific color dye core, reduces the chances of false positives or negatives for increased reliability of the test.

Importantly, no other solution addresses the needs of applications requiring both a high density and high throughput at the same time. Traditional ELISA, real-time PCR and other technologies that excel at high-throughput applications (greater than 1000 samples per day) lack the ability to multiplex more than 5 tests at a time. On the other hand, microarray technology excels in high-density screening (greater than 250-plex tests) — but lacks the reproducibility needed for high-throughput applications.  For applications requiring high throughput, multiplexing and multi parameter testing, LSSL technology stands virtually alone.